Anticoagulation in Cancer Related Stroke "OASIS-CANCER"


Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Age 20 years and older
- Acute ischemic stroke presented within 7 days of symptom onset
- Cancer related stroke: active cancer (diagnosis of cancer within 6 months of stroke onset, any treatment for cancer within the previous 6 months, or recurrent or metastatic cancer) and ischemic stroke which could not be explained by conventional stroke mechanisms including large artery atherosclerosis, cardioembolism, lacunar infarction, or other etiologies (e.g., dissection)
- Signed informed consent or appropriate signed deferral of consent where approved

Exclusion Criteria

- Primary intracranial malignancy
- Incomplete workup for stroke etiology (either vascular or cardiologic studies)
- Any signs of infectious or immunological diseases which may influence plasma D-dimer levels
- Patients with stroke suspected to be caused by the tumor itself (i.e., tumor emboli) or cancer treatment (i.e., chemotherapy-induced stroke)